Distribution date: 11 April 2022 | Final date for Comment: 06 May 2025

This resolution contains provisions on the suitable of drugs that already received the market registration.

Products Covered: HS (3003-3004) - Medicaments

Regulation Type: Regular notification

Distribution date: 11 April 2022 | Final date for Comment: 06 May 2025

This resolution contains provisions on the suitable of drugs that already received the market registration.

Products Covered: HS (3003-3004) - Medicaments

Regulation Type: Regular notification

Distribution date: 11 April 2022 | Final date for Comment: 06 May 2025

This resolution establishes technical definitions and requirements of cosmetics related to skin tanning, as well as labelling warning for tan activators/accelerators.

Products Covered: HS (3304-3307) - Skin tanning related cosmetics

Regulation Type: Regular notification

Distribution date: 11 April 2022 | Final date for Comment: 06 May 2025

This resolution establishes technical definitions and requirements of cosmetics related to skin tanning, as well as labelling warning for tan activators/accelerators.

Products Covered: HS (3304-3307) - Skin tanning related cosmetics

Regulation Type: Regular notification

Distribution date: 11 April 2022 | Final date for Comment: 06 May 2025

This resolution contains provisions on the prohibition of advertising, publicity and promotion, throughout the national territory, of medicines that contain the active principle acetylsalicylic acid and use expressions that refer to the symptoms of other pathologies that are similar to the symptoms of dengue, as a measure of health interest and in special circumstances of risk to health.

Products Covered: HS (3003-3004) - Medicaments

Regulation Type: Regular notification

Distribution date: 11 April 2022 | Final date for Comment: 06 May 2025

This resolution contains provisions on the prohibition of advertising, publicity and promotion, throughout the national territory, of medicines that contain the active principle acetylsalicylic acid and use expressions that refer to the symptoms of other pathologies that are similar to the symptoms of dengue, as a measure of health interest and in special circumstances of risk to health.

Products Covered: HS (3003-3004) - Medicaments

Regulation Type: Regular notification

Distribution date: 11 April 2022 | Final date for Comment: 06 May 2025

This resolution prohibits the isolated use of products that contain paraformaldehyde or formaldehyde, for disinfection and sterilization, regulates the use of products that contain such substances in sterilization equipment.

Products Covered: HS (291260, 291211) - Paraformaldehyde and formaldehyde

Regulation Type: Regular notification

Distribution date: 11 April 2022 | Final date for Comment: 06 May 2025

This resolution prohibits the isolated use of products that contain paraformaldehyde or formaldehyde, for disinfection and sterilization, regulates the use of products that contain such substances in sterilization equipment.

Products Covered: HS (291260, 291211) - Paraformaldehyde and formaldehyde

Regulation Type: Regular notification

Distribution date: 11 April 2022 | Final date for Comment: 06 May 2025

This resolution contains provisions on the conditions of use of lead acetate, formaldehyde, paraformaldehyde and pyrogallol and internalizes GMC MERCOSUR Resolution number 48/2010.

Products Covered: HS (3303, 3304, 3305, 3306, 3307) - Toiletries, cosmetics and perfumes

Regulation Type: Regular notification

Distribution date: 11 April 2022 | Final date for Comment: 06 May 2025

This resolution contains provisions on the conditions of use of lead acetate, formaldehyde, paraformaldehyde and pyrogallol and internalizes GMC MERCOSUR Resolution number 48/2010.

Products Covered: HS (3303, 3304, 3305, 3306, 3307) - Toiletries, cosmetics and perfumes

Regulation Type: Regular notification